2621 - 2630 of 9036 Results
Title
Year
-
OPENTitle: Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammationJournal Name: Mucosal ImmunologyPublisher: Elsevier BVVol: 14Issue #: 3Start Page: 652End Page: 666Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41385-020-00354-7Best OA location URL: https://www.nature.com/articles/s41385-020-00354-7.pdfCitation Count: 40
-
OPENTitle: Genomics transformer for diagnosing Parkinson's diseaseJournal Name: 2022 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI)Publisher: IEEEVol:Issue #:Start Page: 01End Page: 04Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bhi56158.2022.9926815Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9942707Citation Count: 11
-
OPENTitle: Bayesian Longitudinal Modeling of Early Stage Parkinson’s Disease Using DaTscan ImagesJournal Name: Lecture Notes in Computer SciencePublisher: Springer International PublishingVol:Issue #:Start Page: 405End Page: 416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-030-20351-1_31Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10258684/pdf/nihms-1899421.pdfCitation Count: 4
- Application of longitudinal item response theory models to modeling Parkinson’s disease progression2022OPENTitle: Application of longitudinal item response theory models to modeling Parkinson’s disease progressionJournal Name: CPT: Pharmacometrics & Systems PharmacologyPublisher: WileyVol: 11Issue #: 10Start Page: 1382End Page: 1392Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/psp4.12853Best OA location URL: https://doi.org/10.1002/psp4.12853Citation Count: 10
-
OPENTitle: Novel recruitment strategy to enrich forLRRK2mutation carriersJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 3Issue #: 5Start Page: 404End Page: 412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.151Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.151Citation Count: 21
-
RESTRICTEDTitle: Increased odds of bladder and bowel symptoms in early Parkinson's diseaseJournal Name: Neurourology and UrodynamicsPublisher: WileyVol: 37Issue #: 4Start Page: 1344End Page: 1348Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/nau.23443Best OA location URL: http://doi.org/10.1002/nau.23443Citation Count: 12
-
OPENTitle: Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic VariantsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2155End Page: 2162Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29647Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29647Citation Count: 17
-
OPENTitle: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2217End Page: 2225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29197Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9669136Citation Count: 24
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 147
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7